Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Inspiratory resistance decreases limb blood flow in COPD patients with heart failure

Gaspar R. Chiappa, Paulo J.C. Vieira, Daniel Umpierre, Ana Paula S. Corrêa, Danilo C. Berton, Jorge P. Ribeiro, J. Alberto Neder
European Respiratory Journal 2014 43: 1507-1510; DOI: 10.1183/09031936.00166013
Gaspar R. Chiappa
1Exercise Pathophysiology Research Laboratory and Cardiology Division, Hospital de Clinicas de Porto Alegre, Porto Alegre
2Physical Therapy Dept, Serra Gaucha College, Caxias do Sul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gaspar.chiappa@gmail.com
Paulo J.C. Vieira
1Exercise Pathophysiology Research Laboratory and Cardiology Division, Hospital de Clinicas de Porto Alegre, Porto Alegre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Umpierre
1Exercise Pathophysiology Research Laboratory and Cardiology Division, Hospital de Clinicas de Porto Alegre, Porto Alegre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Paula S. Corrêa
1Exercise Pathophysiology Research Laboratory and Cardiology Division, Hospital de Clinicas de Porto Alegre, Porto Alegre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danilo C. Berton
3Pulmonary Division, Hospital de Clínicas de Porto Alegre, Porto Alegre
4Dept of Medicine, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge P. Ribeiro
1Exercise Pathophysiology Research Laboratory and Cardiology Division, Hospital de Clinicas de Porto Alegre, Porto Alegre
4Dept of Medicine, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Alberto Neder
5Pulmonary Function and Clinical Exercise Physiology Unit, Division of Respiratory Diseases, Dept of Medicine, Federal University of São Paulo, São Paulo, Brazil
6Laboratory of Clinical Exercise Physiology (LACEP), Division of Respirology, Dept of Medicine, Queen’s University and Kingston General Hospital, Kingston, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editor:

Chronic heart failure (CHF) with reduced left ventricular ejection fraction is a common and disabling comorbidity of chronic obstructive pulmonary disease (COPD) [1]. Understanding the mechanisms underlying exercise intolerance is paramount to providing a rationale to effectively rehabilitate the fast-growing population of patients with COPD plus CHF.

The inspiratory muscles, in particular, are characteristically overloaded in COPD plus CHF, with greater elastic and resistive work of breathing. Moreover, these muscles might be functionally weakened as ventilation increases during exercise in patients with COPD [2]. It has been postulated that fatiguing contractions would stimulate diaphragmatic thinly myelinated group III and unmyelinated group IV fibres, thereby increasing limb sympathetic outflow and vascular resistance. The so-called respiratory muscle metaboreflex would then redirect blood flow from locomotor to respiratory muscles to avoid, or at least postpone, the impending failure of the “vital pump” [3, 4]. In this context, we previously found marked blood flow reduction to nonactive and active limbs during inspiratory resistive loading in CHF [5]. Work from our laboratory also showed improved peripheral muscle oxygen delivery after respiratory muscle unloading (under stable cardiac output and arterial oxygen content) in CHF-free COPD [6] and COPD-free CHF [7]. It is therefore conceivable that the coexistence of CHF would potentiate the respiratory muscle metaboreflex in patients with a primary diagnosis of COPD.

After giving informed consent, 22 optimally treated patients with moderate-to-severe (Global Initiative for Chronic Obstructive Lung Disease stage II–III) COPD (10 with coexistent CHF, i.e. left ventricular ejection fraction <45% by echocardiography) and 10 age- and sex-matched controls underwent a ramp-incremental exercise test for peak oxygen uptake determination. On a different visit, subjects were randomly assigned to breathe through an inspiratory resistance set at 60% maximal inspiratory pressure (MIP) to task failure (i.e. mouth pressure <80% of the individual target during three consecutive breaths) or 2% MIP for 3 min. While being continuously encouraged by the same investigator, participants maintained a mean±sd breathing frequency of 15±1 breaths·min−1 and duty cycle (inspiratory to total respiratory time ratio) of 0.7±0.1 by following visual feedback. Arterial oxygen saturation measured by pulse oximetry (SpO2), end-tidal carbon dioxide tension (PETCO2) and mean arterial blood pressure (MAP) were measured during the trials. Calf blood flow was obtained by venous occlusion plethysmography (TL-400; Hokanson, Bellevue, WA, USA) and vascular resistance was calculated as MAP/calf blood flow. Between-group comparisons across time points were performed by two-way repeated-measures ANOVA with Bonferroni adjustment. The overall probability of a type I error was set at 5%.

COPD plus CHF patients showed greater forced expiratory volume in 1 s (FEV1) but lower forced vital capacity than their counterparts without CHF. They had the lowest MIP and peak oxygen uptake amongst the three groups (p<0.05; data not shown). Resting calf blood flow was lower (and resistance higher) in this group compared to controls. The 2% MIP trial had no significant effect on the responses of interest (fig. 1a, c and e). Owing to the differences in MIP, COPD plus CHF patients performed the 60% MIP trials at lower absolute loads than COPD and controls (36±5, 50±10 and 68±7 cmH2O, respectively; p<0.01). Time to task failure in these trials was ∼35% and ∼50% lower in the COPD plus CHF group compared with the other groups (185±35, 284±82 and 365±88 s, respectively; p<0.01). Despite shorter trials, calf blood flow was reduced (and vascular resistance increased) to a greater extent in COPD plus CHF than COPD alone (p<0.05) (fig. 1b, d and f). End-test heart rate and SpO2, however, were higher in the former group (96±9 versus 92±13 beats·min−1 and 92±2% versus 84±3%, respectively; p<0.05). Decrements in calf blood flow were inversely related to MIP and peak oxygen uptake across the groups (r= −0.66 and −0.69, respectively; p<0.01).

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Physiological responses to inspiratory resistive loading set at 2% (sham) and 60% maximal inspiratory pressure (MIP) in patients with chronic obstructive pulmonary disease (COPD) or COPD plus chronic heart failure (CHF) and healthy controls. The 2% MIP trials lasted 3 min in all participants. Compared with controls, however, the 60% trials were significantly shorter in the COPD plus CHF group compared with COPD alone and controls, respectively (see main text for actual values). Data are presented as mean±sd. MAP: mean arterial blood pressure. *: p<0.05, COPD plus CHF or COPD versus controls; #: p<0.05, COPD plus CHF versus COPD; ¶: p<0.05, within-group difference from rest.

The present study showed supporting evidence of exacerbated respiratory muscle metaboreflex in patients with COPD plus CHF compared with those with COPD in isolation and healthy controls. Notably, this was observed despite the respiratory muscles having been challenged at lower absolute intensities in this group. CHF per se is associated with sympathetic overstimulation and it could be argued that the disease would exacerbate the metaboreflex regardless of any coexisting condition. In fact, calf vascular resistance was higher in COPD plus CHF even before the inspiratory resistance challenges, which suggests increased resting sympathetic tone in these patients. Considering that patients with CHF alone were not evaluated, it remains uncertain whether impairment in calf blood flow would be greater in COPD plus CHF than CHF matched by haemodynamic impairment. Albeit to a lesser extent (and after longer trials), patients with COPD alone also showed increased vascular resistance. The respiratory muscle metaboreflex is expected to be particularly active when cardiac output is taxed by negative cardiopulmonary interactions such as those elicited by dynamic hyperinflation [8–11]. Our experimental conditions (large inspiratory resistance and duty cycle) probably reduced diaphragmatic blood flow through forceful inspiration and increased the operating lung volumes as the expiratory time became shorter. It should be noted, however, that impaired cardiac output alone is unlikely to fully justify lower calf blood flow in COPD plus CHF than COPD, as vascular resistance was higher in the former group. FEV1 and SpO2 were both greater in COPD plus CHF, which argues against a role of worsening airflow obstruction and hypoxaemia in explaining these findings.

We found significant correlations between lower calf blood flow during the 60% MIP trials and reduced MIP and peak oxygen uptake. This is in line with the notion that the respiratory muscle metaboreflex is likely to be exacerbated in patients with inspiratory muscle weakness [5]. Moreover, the reflex might have contributed to exercise limitation in patients with COPD plus CHF. Previous findings showing concomitant increases in exercise tolerance and leg oxygen delivery after heliox [8, 9] and bronchodilators [10, 11] in COPD also lend support to this notion. The present results, however, cannot be unrestrictedly extrapolated for exercise conditions, as the modulating effects of functional sympatholysis on the peripheral effects of inspiratory resistive loading were not tested.

We acknowledge that neither increased limb muscle sympathetic nerve activity nor respiratory muscle fatigue were experimentally demonstrated in COPD plus CHF. Nevertheless, it is difficult to envisage an alternative explanation for the observed increase in calf vascular resistance with respiratory muscle overloading. Subjects were actively encouraged to sustain the 60% MIP trials and the continuous recording of mouth pressure indicated a pattern of slow and progressive decline towards the threshold for test interruption, which suggests fatigue development rather than lack of motivation. PETCO2 remained stable in all groups, which is reassuring that hyperventilation did not contribute to peripheral vasoconstriction in COPD plus CHF. A relatively young group of patients (typically 45–60 years old) volunteered for study participation and larger effects of inspiratory resistive loading on peripheral blood flow might have been found had we evaluated older patients with larger perfusion deficits.

We conclude that volitional efforts against an inspiratory resistance to task failure were associated with increased vascular resistance and lower blood flow in the resting calf of patients with COPD who had comorbid CHF. This is the first study to suggest augmented respiratory muscle metaboreflex activity in these patients, a deleterious adjustment that might contribute to poor tolerance to exertion. Whether inspiratory muscle training could mitigate this phenomenon, as previously shown in healthy subjects [12], and contribute to enhance patients’ exercise capacity remains open to investigation.

Footnotes

  • Conflict of interest: None declared.

  • Received September 21, 2013.
  • Accepted October 25, 2013.
  • ©ERS 2014

References

  1. ↵
    1. Macchia A,
    2. Rodriguez Moncalvo JJ,
    3. Kleinert M,
    4. et al
    . Unrecognised ventricular dysfunction in COPD. Eur Respir J 2012; 39: 51–58.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Gosker HR,
    2. Lencer NH,
    3. Franssen FM,
    4. et al
    . Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003; 123: 1416–1424.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. St Croix CM,
    2. Morgan BJ,
    3. Wetter TJ,
    4. et al
    . Fatiguing inspiratory muscle work causes reflex sympathetic activation in humans. J Physiol 2000; 529: 493–504.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Harms CA,
    2. Wetter TJ,
    3. McClaran SR,
    4. et al
    . Effects of respiratory muscle work on cardiac output and its distribution during maximal exercise. J Appl Physiol 1998; 85: 609–618.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Chiappa GR,
    2. Roseguini BT,
    3. Vieira PJ,
    4. et al
    . Inspiratory muscle training improves blood flow to resting and exercising limbs in patients with chronic heart failure. J Am Coll Cardiol 2008; 51: 1663–1671.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Borghi-Silva A,
    2. Oliveira CC,
    3. Carrascosa C,
    4. et al
    . Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPD. Thorax 2008; 63: 910–915.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Borghi-Silva A,
    2. Carrascosa C,
    3. Oliveira CC,
    4. et al
    . Effects of respiratory muscle unloading on leg muscle oxygenation and blood volume during high-intensity exercise in chronic heart failure. Am J Physiol Heart Circ Physiol 2008; 294: H2465–H2472.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Chiappa GR,
    2. Queiroga F Jr.,
    3. Meda E,
    4. et al
    . Heliox improves oxygen delivery and utilization during dynamic exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179: 1004–1010.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Laveneziana P,
    2. Valli G,
    3. Onorati P,
    4. et al
    . Effect of heliox on heart rate kinetics and dynamic hyperinflation during high-intensity exercise in COPD. Eur J Appl Physiol 2011; 111: 225–234.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Laveneziana P,
    2. Palange P,
    3. Ora J,
    4. et al
    . Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD. Eur J Appl Physiol 2009; 107: 633–643.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Berton DC,
    2. Barbosa PB,
    3. Takara LS,
    4. et al
    . Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD. Thorax 2010; 65: 588–593.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Witt JD,
    2. Guenette JA,
    3. Rupert JL,
    4. et al
    . Inspiratory muscle training attenuates the human respiratory muscle metaboreflex. J Physiol 2007; 584: 1019–1028.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 43 Issue 5 Table of Contents
European Respiratory Journal: 43 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Inspiratory resistance decreases limb blood flow in COPD patients with heart failure
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Inspiratory resistance decreases limb blood flow in COPD patients with heart failure
Gaspar R. Chiappa, Paulo J.C. Vieira, Daniel Umpierre, Ana Paula S. Corrêa, Danilo C. Berton, Jorge P. Ribeiro, J. Alberto Neder
European Respiratory Journal May 2014, 43 (5) 1507-1510; DOI: 10.1183/09031936.00166013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Inspiratory resistance decreases limb blood flow in COPD patients with heart failure
Gaspar R. Chiappa, Paulo J.C. Vieira, Daniel Umpierre, Ana Paula S. Corrêa, Danilo C. Berton, Jorge P. Ribeiro, J. Alberto Neder
European Respiratory Journal May 2014, 43 (5) 1507-1510; DOI: 10.1183/09031936.00166013
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Corticosteroids in COVID-19: one size does not fit all
  • Self- versus professional-collected swabs for SARS-CoV-2 rapid test
  • Free-breathing MRI for monitoring ventilation changes in paediatric CF
Show more Agora

Research letters

  • Self- versus professional-collected swabs for SARS-CoV-2 rapid test
  • Free-breathing MRI for monitoring ventilation changes in paediatric CF
  • Challenges of nasal/pharyngeal swabs during the COVID-19 pandemic
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society